Intervention not reported
Temperature ‐ RCT/CCT axillary · children 9 months to 15 years old
The intervention may leads to higher temperature ‐ RCT/CCT axillary (low certainty).
1 finding from 1 review
Intervention not reported
Temperature ‐ RCT/CCT rectal · children 9 months to 15 years old
The intervention showed no clear difference in temperature ‐ RCT/CCT rectal (low certainty).
1 finding from 1 review
Intervention not reported
Cohort studies household contacts ‐ 1 dose · children 9 months to 15 years old
The intervention may leads to lower cohort studies household contacts ‐ 1 dose (low certainty).
1 finding from 1 review
Intervention not reported
Temperature ‐ RCT/CCT measurement site not reported · children 9 months to 15 years old
The intervention showed no clear difference in temperature ‐ RCT/CCT measurement site not reported (high certainty).
1 finding from 1 review
Intervention not reported
Temperature ‐ cohort studies orally · children 9 months to 15 years old
It is very uncertain whether the intervention changes temperature ‐ cohort studies orally (very low certainty).
1 finding from 1 review
Intervention not reported
Temperature ‐ cohort studies measurement site not reported · children 9 months to 15 years old
It is very uncertain whether the intervention changes temperature ‐ cohort studies measurement site not reported (very low certainty).
1 finding from 1 review
Intervention not reported
Rash ‐ cohort studies · children 9 months to 15 years old
It is very uncertain whether the intervention changes rash ‐ cohort studies (very low certainty).
1 finding from 1 review
Intervention not reported
Lymphadenopathy ‐ RCT/CCT · children 9 months to 15 years old
The intervention showed no clear difference in lymphadenopathy ‐ RCT/CCT (moderate certainty).
1 finding from 1 review
Intervention not reported
Lymphadenopathy ‐ cohort studies · children 9 months to 15 years old
It is very uncertain whether the intervention changes lymphadenopathy ‐ cohort studies (very low certainty).
1 finding from 1 review
Intervention not reported
Coryza ‐ RCT/CCT · children 9 months to 15 years old
The intervention showed no clear difference in coryza ‐ RCT/CCT (moderate certainty).
1 finding from 1 review
Intervention not reported
Coryza ‐ cohort studies · children 9 months to 15 years old
The intervention may leads to higher coryza ‐ cohort studies (low certainty).
1 finding from 1 review
Intervention not reported
URTI (rhinitis pharyngitis) ‐ RCT/CCT · children 9 months to 15 years old
The intervention showed no clear difference in URTI (rhinitis pharyngitis) ‐ RCT/CCT (low certainty).
1 finding from 1 review
Intervention not reported
URTI (rhinitis pharyngitis) ‐ cohort studies · children 9 months to 15 years old
It is very uncertain whether the intervention changes URTI (rhinitis pharyngitis) ‐ cohort studies (very low certainty).
1 finding from 1 review
Intervention not reported
Cohort studies household contacts ‐ 2 doses · children 9 months to 15 years old
The intervention may leads to lower cohort studies household contacts ‐ 2 doses (low certainty).
1 finding from 1 review
Intervention not reported
Cough ‐ RCT/CCT · children 9 months to 15 years old
The intervention showed no clear difference in cough ‐ RCT/CCT (low certainty).
1 finding from 1 review
Intervention not reported
Rash ‐ RCT/CCT · children 9 months to 15 years old
The intervention leads to higher rash ‐ RCT/CCT (high certainty).
1 finding from 1 review
Intervention not reported
Case‐control: MMR (risk interval from 0 to 90 days) · children 9 months to 15 years old
The intervention showed no clear difference in case‐control: MMR (risk interval from 0 to 90 days) (low certainty).
1 finding from 1 review
Intervention not reported
Self‐controlled case series/person‐time cohort · children 9 months to 15 years old
The intervention showed no clear difference in self‐controlled case series/person‐time cohort (low certainty).
1 finding from 1 review
Intervention not reported
Case‐control ‐ Jeryl Lynn ‐ risk interval 0 to 30 days · children 9 months to 15 years old
The intervention showed no clear difference in case‐control ‐ Jeryl Lynn ‐ risk interval 0 to 30 days (low certainty).
1 finding from 1 review
Intervention not reported
Case cross‐over ‐ Urabe or Hoshino · children 9 months to 15 years old
The intervention may leads to higher case cross‐over ‐ Urabe or Hoshino (low certainty).
1 finding from 1 review